Shore Institute For Reproductive Medicine

CLIA Laboratory Citation Details

3
Total Citations
15
Total Deficiencyies
8
Unique D-Tags
CMS Certification Number 31D0886776
Address 475 Route 70, Lakewood, NJ, 08701
City Lakewood
State NJ
Zip Code08701
Phone732 363-4777
Lab DirectorALLEN MORGAN

Citation History (3 surveys)

Survey - June 7, 2023

Survey Type: Standard

Survey Event ID: DHRU11

Deficiency Tags: D5211 D5417 D5469 D5417 D3037 D5211 D6086 D5469 D6086

Summary:

Summary Statement of Deficiencies D3037 RETENTION REQUIREMENTS CFR(s): 493.1105(a)(4) Proficiency testing records. Retain all proficiency testing records for at least 2 years. This STANDARD is not met as evidenced by: Based on surveyor review of Proficiency Testing (PT) records and interview with the Testing Personnel (TP), the laboratory failed to retain graded results for Endocrinology performed with the American Association of Bioanalysts (AAB). The findings include: 1) There were no Graded results for PT events Q2-2022 and Q3- 2021. 2) The TP confirmed on 6/7/23 at 10:15 am that all PT graded results were not retained. D5211 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(a) The laboratory must review and evaluate the results obtained on proficiency testing performed as specified in subpart H of this part. This STANDARD is not met as evidenced by: Based on surveyor review of Proficiency Testing (PT) records and interview with the Testing Personnel (TP), the laboratory failed to evaluate coded results obtained from the American Association of Bioanalysts (AAB) for Andrology & Embryology events S1 and S2 2022. The findings include: 1. The laboratory did not evaluate Code ? (This score may not truly evaluate performance for this specimen which was not graded because of a lack of participant consensus) response from AAB for the following: b) Sperm Cell ID sample 3 event S1-2022. c) Sperm Cell ID sample 7 event S2-2022. 2. The TP confirmed on 6/7/23 at 10:30 am that the laboratory failed to evaluate the above mentioned coded results. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- D5417 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(d) Reagents, solutions, culture media, control materials, calibration materials, and other supplies must not be used when they have exceeded their expiration date, have deteriorated, or are of substandard quality. This STANDARD is not met as evidenced by: Based on surveyor observation of Endocrinology reagents and interview with the Testing Personnel (TP), the laboratory failed to discard expired Access Substrate reagent from 5/31/23 to the date of survey. The finding include: 1. Access Substrate reagent Lot 40431 expired 5/31/23. 2. The TP confirmed on 6/7/23 at 11:30 am that the laboratory failed to discard expired reagent. D5469 CONTROL PROCEDURES CFR(s): 493.1256(d)(10)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- Establish or verify the criteria for acceptability of all control materials. (i) When control materials providing quantitative results are used, statistical parameters (for example, mean and standard deviation) for each batch and lot number of control materials must be defined and available. (ii) The laboratory may use the stated value of a commercially assayed control material provided the stated value is for the methodology and instrumentation employed by the laboratory and is verified by the laboratory. (iii) Statistical parameters for unassayed control materials must be established over time by the laboratory through concurrent testing of control materials having previously determined statistical parameters. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on the lack of Quality Control Verification (QCV) records and interview with the Testing Personnel (TP), the laboratory failed to verify QC material before use for Semen Analyses and endocrinology on the date of survey. The findings includes, 1) There was no documented evidence that QCV was performed on Bio Rad lyphochek immunoassay plus controls lot # 4030. 2) There was no documented evidence that QCV was performed on Accubeads Lot # 211410351 3) The TP confirmed 6/7/23 at 11:15 am that QC material was not verified before putting in use. D6086 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(3)(ii) The laboratory director must ensure that verification procedures used are adequate to determine the accuracy, precision, and other pertinent performance characteristics of the method. This STANDARD is not met as evidenced by: Based on surveyor review of the Performance Specification (PS) records and interview with the testing Personnel (TP), the LD failed to ensure that PS were adequate to perform Endocrinology tests performed on the Beckman coulter access 2 -- 2 of 3 -- analyzer on the date of survey. The findings include: 1. The laboratory did not verify Patient Normal Range. 2. The laboratory did not verify the Laboratory Information system (LIS). 3. The TP confirmed on 6/7/23 at 11:15 am that not all PS were adequate. -- 3 of 3 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - February 7, 2020

Survey Type: Standard

Survey Event ID: 4S6U11

Deficiency Tags: D2100 D6016 D2100 D6016

Summary:

Summary Statement of Deficiencies D2100 ENDOCRINOLOGY CFR(s): 493.843(c) Failure to participate in a testing event is unsatisfactory performance and results in a score of 0 for the testing event. Consideration may be given to those laboratories failing to participate in a testing event only if-- (1) Patient testing was suspended during the time frame allotted for testing and reporting proficiency testing results; (2) The laboratory notifies the inspecting agency and the proficiency testing program within the time frame for submitting proficiency testing results of the suspension of patient testing and the circumstances associated with failure to perform tests on proficiency testing samples; and (3) The laboratory participated in the previous two proficiency testing events. This STANDARD is not met as evidenced by: Based on surveyor review of the Proficiency Testing (PT) records and interview with the General Supervisor (GS), the laboratory failed to participate in American Association of Bioanalysts PT for Q1 of 2019 for Human Chorionic Gonadotropin (HCG) test. The GS confirmed on 2/7/20 at 11:30 am that the laboratory did not participate in event Q1 of 2019 for HCG. D6016 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(4)(i) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(4)(i) Ensure that the proficiency testing samples are tested as required under Subpart H of this part; Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- This STANDARD is not met as evidenced by: Based on surveyor review of Proficiency Testing (PT) records and interview with the General Supervisor (GS), the Laboratory Director (LD) failed to ensure that PT samples were tested for Human Chorionic Gonadotropin (HCG) in Q1 of 2019 with American Association of Bioanalysts. The GS confirmed on 2/7/20 at 11:31 pm that the LD did not ensure that PT samples were tested. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - February 1, 2018

Survey Type: Standard

Survey Event ID: 3BPE11

Deficiency Tags: D5783 D5783

Summary:

Summary Statement of Deficiencies D5783

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access